Our current investigation shows that population distributions are broadly similar across three recent, large investigations of visual field progression rates (
Fig. 4) despite differences in the specific details of each study, although it is clear that a single model is not the best description of all the datasets analyzed. Is having a model that performs well “on average,” such as the modified hyperbolic secant in the current study, of any benefit, given these distributional differences? In empirical Bayes methods, the distribution of the population (the prior distribution) is estimated from the empirical data itself
8 and so is therefore very well matched to the particular cohort of patients analyzed in terms of such factors as glaucoma type, ethnicity, and testing procedure. While producing very encouraging results, empirical Bayes probably represent an upper boundary on what performance benefits might be expected, as any commercially developed, widely-implemented progression tool will almost certainly assume a population distribution that differs from that of the patients the tool is eventually applied to. Indeed, outside of a research environment, the precise distribution of glaucoma rates in a given clinical population is almost certainly unknown and so recourse to some form of “average” distribution is required, at least initially. Our data gives some idea of what variation might be expected between populations of different geography and patient inclusion criteria (
Fig. 4,
Table 1), and it has been argued that at least one of our hospital-based datasets does not represent a selected subgroup of glaucoma patients distinct from that in the wider community.
13 Previous work suggests that modest performance benefits of Bayesian methods still persists despite discrepancies between the lower tail of the prior distribution and the patient data (each modelled with a modified hyperbolic secant) that were slightly greater than those seen in
Table 1, suggesting that use of our distribution defined by average parameters (
Fig. 4, thick line) may still have some benefits in improving individual visual field progression rate estimates. An average prior could then be made to better reflect the particular patient group to which it is applied by progressively updating the prior to incorporate information from each patient's test result, in an approach similar to that proposed for determining perimetric thresholds.
19 Improvements from Bayesian methods are likely to be modest, however, owing to the fact that the distribution of progression rates in the population is quite broad and so does not constrain individual progression rate estimates much.
6 Even if a parametric model were found that fitted the population distribution perfectly (as is very nearly the case for the modified Cauchy distribution fit to the Canadian data, and the modified hyperbolic secant fit to the Swedish data), the broad nature of the fit remains: hence, the goodness of fit of a model is not a guarantee of its use in a Bayesian method.